Product Information

BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE is a generic product labeled by Actavis Pharma, Inc., priced at $0.3526 per EA under NDC 00591264005. Its NADAC has been published 661 times since Mar 19, 2014.

FDA first approved this application on Nov 16, 2009. Its Orange Book therapeutic-equivalence code is AA.

The High Outlier badge above means this manufacturer's average price in the Butalbital, Acetaminophen, and Caffeine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE

Butalbital, Acetaminophen, and Caffeine
$0.3526per EA
High Outlier

Strength

300; 50; 40 mg/1; mg/1; mg/1

NDC

00591264005

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA040885

FDA Approved

11/16/2009

TE Code

AA

On Market Since

7/29/2013

Pharmacological Classes

Barbiturate
Barbiturates
Central Nervous System Stimulant
Central Nervous System Stimulation
Methylxanthine
Xanthines

Price Statistics

The NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE has been published 661 times since Mar 19, 2014, and over the history we have for it it has declined 82.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3526 per EA
All-time high$2.6900 (Jul 15, 2015)
All-time low$0.3110 (Apr 22, 2026)
52-week high$0.3526
52-week low$0.3110
Median price$1.4911
Average price$1.3631
Largest weekly change+34.5% (Jun 19, 2024)
Weeks tracked661
Tracking sinceMar 19, 2014

Price History

1W

0.0%

1M

+11.5%

3M

+10.2%

6M

+13.4%

1Y

+2.9%

3Y

-41.1%

5Y

-44.1%

All

-82.0%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE, manufactured by Actavis Pharma, Inc., is $0.3526 per EA (NDC 00591264005), effective Nov 11, 2026.

How has the price of BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE has declined 82.0%. It has been tracked across 661 weekly CMS publications since Mar 19, 2014.

What are the highest and lowest recorded NADAC prices for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE?

Since Mar 19, 2014, the NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE has ranged from a low of $0.3110 (Apr 22, 2026) to a high of $2.6900 (Jul 15, 2015), with a median of $1.4911 per EA.

Are there cheaper alternatives to BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE, is $0.3355 per EA — about 5% below BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE.

Who manufactures BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE?

BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE (NDC 00591264005) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.